FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch Print this page PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Twirla (levonorgestrel and ethinyl estradiol) transdermal system. INDICATION AND… Read More »